Inflammatory Optic Neuritis: From Multiple Sclerosis to Neuromyelitis Optica

Por de Seze, Jérôme
Publicado no Neuroophthalmology (2013)

Current and future treatment approaches for neuromyelitis optica

Por Collongues, Nicolas, de Seze, Jérôme
Publicado em 2011

An update on the evidence for the efficacy and safety of rituximab in the management of neuromyelitis optica

Por Collongues, Nicolas, de Seze, Jérôme
Publicado no Ther Adv Neurol Disord (2016)

Patient perceptions of multiple sclerosis and its treatment

Por de Seze, Jérôme, Borgel, Florent, Brudon, Frédérique
Publicado em 2012

A Case of Paraneoplastic Demyelinating Motor Polyneuropathy

Por Mostoufizadeh, Sohrab, Souri, Maryam, de Seze, Jérôme
Publicado em 2012

Teriflunomide in Patients with Relapsing–Remitting Forms of Multiple Sclerosis

Por Chan, Andrew, de Seze, Jérôme, Comabella, Manuel
Publicado no CNS Drugs (2016)

Inflammatory-like presentation of CADASIL: a diagnostic challenge

Por Collongues, Nicolas, Derache, Nathalie, Blanc, Frédéric, Labauge, Pierre, de Seze, Jérôme, Defer, Gilles
Publicado em 2012

Review of Animal Models of Neuromyelitis Optica

Por Jones, Melina V., Collongues, Nicolas, de Seze, Jerome, Kinoshita, Makoto, Nakatsuji, Yuji, Levy, Michael
Publicado em 2012

Induced Brain Plasticity after a Facilitation Programme for Autobiographical Memory in Multiple Sclerosis: A Preliminary Study

Por Ernst, Alexandra, Botzung, Anne, Gounot, Daniel, Sellal, François, Blanc, Frédéric, de Seze, Jerome, Manning, Liliann
Publicado em 2012

Neutralizing antibodies and fatigue as predictors of low response to interferon-beta treatment in patients with multiple sclerosis

Por Manceau, Philippe, Latarche, Clotilde, Pittion, Sophie, Edan, Gilles, de Sèze, Jérôme, Massart, Catherine, Debouverie, Marc
Publicado no BMC Neurol (2014)

Chronic Bickerstaff’s encephalitis with cognitive impairment, a reality?

Por Renaud, Mathilde, Aupy, Jérôme, Camuset, Guillaume, Collongues, Nicolas, Chanson, Jean-Baptiste, de Seze, Jérôme, Blanc, Frédéric
Publicado em 2014

Evaluation of Clinical Interest of Anti-Aquaporin-4 Autoantibody Followup in Neuromyelitis Optica

Por Chanson, Jean-Baptiste, Alame, Melissa, Collongues, Nicolas, Blanc, Frédéric, Fleury, Marie, Rudolf, Gabrielle, de Seze, Jérôme, Vincent, Thierry
Publicado em 2013

Tibial Muscular Dystrophy Is a Titinopathy Caused by Mutations in TTN, the Gene Encoding the Giant Skeletal-Muscle Protein Titin

Por Hackman, Peter, Vihola, Anna, Haravuori, Henna, Marchand, Sylvie, Sarparanta, Jaakko, de Seze, Jerome, Labeit, Siegfried, Witt, Christian, Peltonen, Leena, Richard, Isabelle, Udd, Bjarne
Publicado em 2002

Anti-MOG antibodies are present in a subgroup of patients with a neuromyelitis optica phenotype

Por Pröbstel, Anne-Katrin, Rudolf, Gabrielle, Dornmair, Klaus, Collongues, Nicolas, Chanson, Jean-Baptiste, Sanderson, Nicholas SR, Lindberg, Raija LP, Kappos, Ludwig, de Seze, Jérôme, Derfuss, Tobias
Publicado no J Neuroinflammation (2015)

White Matter Atrophy and Cognitive Dysfunctions in Neuromyelitis Optica

Por Blanc, Frederic, Noblet, Vincent, Jung, Barbara, Rousseau, François, Renard, Felix, Bourre, Bertrand, Longato, Nadine, Cremel, Nadjette, Di Bitonto, Laure, Kleitz, Catherine, Collongues, Nicolas, Foucher, Jack, Kremer, Stephane, Armspach, Jean-Paul, de Seze, Jerome
Publicado em 2012

MS disease activity in RESTORE: A randomized 24-week natalizumab treatment interruption study

Por Fox, Robert J., Cree, Bruce A.C., De Sèze, Jerome, Gold, Ralf, Hartung, Hans-Peter, Jeffery, Douglas, Kappos, Ludwig, Kaufman, Michael, Montalbán, Xavier, Weinstock-Guttman, Bianca, Anderson, Britt, Natarajan, Amy, Ticho, Barry, Duda, Petra
Publicado em 2014

Cognitive Dysfunction and Dementia in Primary Sjögren's Syndrome

Por Blanc, Frederic, Longato, Nadine, Jung, Barbara, Kleitz, Catherine, Di Bitonto, Laure, Cretin, Benjamin, Collongues, Nicolas, Sordet, Christelle, Fleury, Marie, Poindron, Vincent, Gottenberg, Jacques-Eric, Anne, Olivier, Lipsker, Dan, Martin, Thierry, Sibilia, Jean, de Seze, Jérôme
Publicado em 2013

MD1003 (high-dose biotin) for the treatment of progressive multiple sclerosis: A randomised, double-blind, placebo-controlled study

Por Tourbah, Ayman, Lebrun-Frenay, Christine, Edan, Gilles, Clanet, Michel, Papeix, Caroline, Vukusic, Sandra, De Sèze, Jerome, Debouverie, Marc, Gout, Olivier, Clavelou, Pierre, Defer, Gilles, Laplaud, David-Axel, Moreau, Thibault, Labauge, Pierre, Brochet, Bruno, Sedel, Frédéric, Pelletier, Jean
Publicado no Mult Scler (2016)

MRI characteristics of neuromyelitis optica spectrum disorder: An international update

Por Kim, Ho Jin, Paul, Friedemann, Lana-Peixoto, Marco A., Tenembaum, Silvia, Asgari, Nasrin, Palace, Jacqueline, Klawiter, Eric C., Sato, Douglas K., de Seze, Jérôme, Wuerfel, Jens, Banwell, Brenda L., Villoslada, Pablo, Saiz, Albert, Fujihara, Kazuo, Kim, Su-Hyun
Publicado no Neurology (2015)

Double-Blind Controlled Randomized Trial of Cyclophosphamide versus Methylprednisolone in Secondary Progressive Multiple Sclerosis

Por Brochet, Bruno, Deloire, Mathilde S. A., Perez, Paul, Loock, Timothé, Baschet, Louise, Debouverie, Marc, Pittion, Sophie, Ouallet, Jean-Christophe, Clavelou, Pierre, de Sèze, Jérôme, Collongues, Nicolas, Vermersch, Patrick, Zéphir, Hélène, Castelnovo, Giovanni, Labauge, Pierre, Lebrun, Christine, Cohen, Mikael, Ruet, Aurélie
Publicado no PLoS One (2017)